Rezultati - Francesco Cognetti

Refine Results
  1. 1
    First-line therapy in HER2 positive metastatic breast cancer: is the mosaic fully completed or are we missing additional pieces?

    First-line therapy in HER2 positive metastatic breast cancer: is the mosaic fully completed or are we missing additional pieces? od Alessandra Fabi, Paola Malaguti, Sabrina Vari, Francesco Cognetti

    Izdano 2016
    Polni tekst Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  2. 2
    The course of cancer related fatigue up to ten years in early breast cancer patients: What impact in clinical practice?

    The course of cancer related fatigue up to ten years in early breast cancer patients: What impact in clinical practice? od Alessandra Fabi, Chiara Falcicchio, Diana Giannarelli, Gabriella Maggi, Francesco Cognetti, Patrizia Pugliese

    Izdano 2017
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  3. 3
    RANKL/RANK/OPG system beyond bone remodeling: involvement in breast cancer and clinical perspectives

    RANKL/RANK/OPG system beyond bone remodeling: involvement in breast cancer and clinical perspectives od Marco Infante, Alessandra Fabi, Francesco Cognetti, Stefania Gorini, Massimiliano Caprio, Andrea Fabbri

    Izdano 2019
    Polni tekst Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  4. 4
    Tumor Microenvironment: Implications in Melanoma Resistance to Targeted Therapy and Immunotherapy

    Tumor Microenvironment: Implications in Melanoma Resistance to Targeted Therapy and Immunotherapy od Italia Falcone, Fabiana Conciatori, Chiara Bazzichetto, G. Ferretti, Francesco Cognetti, Ludovica Ciuffreda, Michèle Milella

    Izdano 2020
    Polni tekst Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  5. 5
    mTOR Cross-Talk in Cancer and Potential for Combination Therapy

    mTOR Cross-Talk in Cancer and Potential for Combination Therapy od Fabiana Conciatori, Ludovica Ciuffreda, Chiara Bazzichetto, Italia Falcone, Sara Pilotto, Emilio Bria, Francesco Cognetti, Michèle Milella

    Izdano 2018
    Polni tekst Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  6. 6
    Role of mTOR Signaling in Tumor Microenvironment: An Overview

    Role of mTOR Signaling in Tumor Microenvironment: An Overview od Fabiana Conciatori, Chiara Bazzichetto, Italia Falcone, Sara Pilotto, Emilio Bria, Francesco Cognetti, Michèle Milella, Ludovica Ciuffreda

    Izdano 2018
    Polni tekst Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  7. 7
    PTEN as a Prognostic/Predictive Biomarker in Cancer: An Unfulfilled Promise?

    PTEN as a Prognostic/Predictive Biomarker in Cancer: An Unfulfilled Promise? od Chiara Bazzichetto, Fabiana Conciatori, Matteo Pallocca, Italia Falcone, Maurizio Fanciulli, Francesco Cognetti, Michèle Milella, Ludovica Ciuffreda

    Izdano 2019
    Polni tekst Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  8. 8
    PTEN Function at the Interface between Cancer and Tumor Microenvironment: Implications for Response to Immunotherapy

    PTEN Function at the Interface between Cancer and Tumor Microenvironment: Implications for Response to Immunotherapy od Fabiana Conciatori, Chiara Bazzichetto, Italia Falcone, Ludovica Ciuffreda, G. Ferretti, Sabrina Vari, Virginia Ferraresi, Francesco Cognetti, Michèle Milella

    Izdano 2020
    Polni tekst Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  9. 9
    Benefit of taxanes as adjuvant chemotherapy for early breast cancer

    Benefit of taxanes as adjuvant chemotherapy for early breast cancer od Emilio Bria, Cecilia Nisticò, Federica Cuppone, Paolo Carlini, Mariangela Ciccarese, Michèle Milella, Guido Natoli, E. Terzoli, Francesco Cognetti, Diana Giannarelli

    Izdano 2006
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  10. 10
    Chordoma: clinical characteristics, management and prognosis of a case series of 25 patients

    Chordoma: clinical characteristics, management and prognosis of a case series of 25 patients od Virginia Ferraresi, Carmen Nuzzo, Carmine Zoccali, Ferdinando Marandino, Antonello Vidiri, Nicola Salducca, Massimo Zeuli, Diana Giannarelli, Francesco Cognetti, R. Biagini

    Izdano 2010
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  11. 11
    Cetuximab plus chronomodulated irinotecan, 5-fluorouracil, leucovorin and oxaliplatin as neoadjuvant chemotherapy in colorectal liver metastases: POCHER trial

    Cetuximab plus chronomodulated irinotecan, 5-fluorouracil, leucovorin and oxaliplatin as neoadjuvant chemotherapy in colorectal liver metastases: POCHER trial od Carlo Garufi, Angela Torsello, Salvatore Tumolo, Giuseppe Maria Ettorre, Massimo Zeuli, Carla Campanella, Giovanni Vennarecci, Marcella Mottolese, Isabella Sperduti, Francesco Cognetti

    Izdano 2010
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  12. 12
    Overcoming resistance to molecularly targeted anticancer therapies: Rational drug combinations based on EGFR and MAPK inhibition for solid tumours and haematologic malignancies

    Overcoming resistance to molecularly targeted anticancer therapies: Rational drug combinations based on EGFR and MAPK inhibition for solid tumours and haematologic malignancies od Giampaolo Tortora, Roberto Bianco, Gennaro Daniele, Fortunato Ciardiello, James A. McCubrey, Maria Rosaria Ricciardi, Ludovica Ciuffreda, Francesco Cognetti, Agostino Tafuri, Michèle Milella

    Izdano 2007
    Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  13. 13
    Outcome of advanced NSCLC patients harboring sensitizing EGFR mutations randomized to EGFR tyrosine kinase inhibitors or chemotherapy as first-line treatment: a meta-analysis

    Outcome of advanced NSCLC patients harboring sensitizing EGFR mutations randomized to EGFR tyrosine kinase inhibitors or chemotherapy as first-line treatment: a meta-analysis od Emilio Bria, Michèle Milella, Federica Cuppone, Silvia Novello, A. Ceribelli, V. Vaccaro, Isabella Sperduti, Alain Gelibter, Giorgio V. Scagliotti, Francesco Cognetti, Diana Giannarelli

    Izdano 2011
    Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  14. 14
    Morphologic and Molecular Landscape of Pancreatic Cancer Variants as the Basis of New Therapeutic Strategies for Precision Oncology

    Morphologic and Molecular Landscape of Pancreatic Cancer Variants as the Basis of New Therapeutic Strategies for Precision Oncology od Chiara Bazzichetto, Claudio Luchini, Fabiana Conciatori, Vanja Vaccaro, Ilaria Di Cello, Paola Mattiolo, Italia Falcone, G. Ferretti, Aldo Scarpa, Francesco Cognetti, Michèle Milella

    Izdano 2020
    Polni tekst Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  15. 15
    Gemcitabine‐based combinations for inoperable pancreatic cancer: Have we made real progress?

    Gemcitabine‐based combinations for inoperable pancreatic cancer: Have we made real progress? od Emilio Bria, Michèle Milella, Alain Gelibter, Federica Cuppone, Maria Simona Pino, Enzo Maria Ruggeri, Paolo Carlini, Cecilia Nisticò, E. Terzoli, Francesco Cognetti, Diana Giannarelli

    Izdano 2007
    Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  16. 16
    PTEN: Multiple Functions in Human Malignant Tumors

    PTEN: Multiple Functions in Human Malignant Tumors od Michèle Milella, Italia Falcone, Fabiana Conciatori, Ursula Cesta Incani, Anais Del Curatolo, Nicola Inzerilli, Carmen Nuzzo, Vanja Vaccaro, Sabrina Vari, Francesco Cognetti, Ludovica Ciuffreda

    Izdano 2015
    Polni tekst Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  17. 17
    Clinical outcome of patients with brain metastases from HER2-positive breast cancer treated with lapatinib and capecitabine

    Clinical outcome of patients with brain metastases from HER2-positive breast cancer treated with lapatinib and capecitabine od Giulio Metro, Jennifer Foglietta, Michelangelo Russillo, Lucia Stocchi, Antonello Vidiri, Diana Giannarelli, Lucio Crinò, Paola Papaldo, Marcella Mottolese, Francesco Cognetti, Alessandra Fabi, Stefania Gori

    Izdano 2010
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  18. 18
    Precision Medicine and Melanoma: Multi-Omics Approaches to Monitoring the Immunotherapy Response

    Precision Medicine and Melanoma: Multi-Omics Approaches to Monitoring the Immunotherapy Response od Fabio Valenti, Italia Falcone, Sara Ungania, Flora Desiderio, Patrizio Giacomini, Chiara Bazzichetto, Fabiana Conciatori, Enzo Gallo, Francesco Cognetti, Gennaro Ciliberto, Aldo Morrone, Antonino Guerrisi

    Izdano 2021
    Polni tekst Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  19. 19
    Magnitude of benefit of the addition of bevacizumab to first-line chemotherapy for metastatic colorectal cancer: meta-analysis of randomized clinical trials

    Magnitude of benefit of the addition of bevacizumab to first-line chemotherapy for metastatic colorectal cancer: meta-analysis of randomized clinical trials od Fotios Loupakis, Emilio Bria, Vanja Vaccaro, Federica Cuppone, Michèle Milella, Paolo Carlini, Chiara Cremolini, Lisa Salvatore, Alfredo Falcone, Paola Muti, Isabella Sperduti, Diana Giannarelli, Francesco Cognetti

    Izdano 2010
    Polni tekst Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  20. 20
    Large Randomized Study of Thymosin α 1, Interferon Alfa, or Both in Combination With Dacarbazine in Patients With Metastatic Melanoma

    Large Randomized Study of Thymosin α 1, Interferon Alfa, or Both in Combination With Dacarbazine in Patients With Metastatic Melanoma od Michele Maio, Andrzej Maćkiewicz, Alessandro Testori, Uwe Trefzer, Virginia Ferraresi, Jacek Jassem, Claus Garbe, Thierry Lesimple, B. Guillot, Pere Gascón, Katalin Gilde, Roberto Camerini, Francesco Cognetti

    Izdano 2010
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:

Iskalna orodja: